Active Gαi/o mutants accelerate breast tumor metastasis via the c-Src pathway

Abstract

Constitutively active mutations in the G[alpha]i2 and G[alpha]oA subunits of heterotrimeric G proteins have been identified in several human cancers including breast cancer, but their functional significance in tumorigenesis and metastasis has not been well characterized. In this study, we show that expression of the constitutively active G[alpha]oAR243H and G[alpha]i2R179C mutants alone was insufficient to induce mammary tumor formation in mice. However, in transgenic mouse models of breast cancer induced by Neu expression or PTEN loss, we found that the G[alpha]i2R179C mutant enhanced spontaneous lung metastasis while having no effect on primary tumor initiation and growth. Additionally, we observed that ectopic expression of the G[alpha]oAR243H and G[alpha]i2R179C mutants in tumor cells promote cell migration in vitro as well as dissemination into multiple organs in vivo by activating c-Src signaling. Thus, our study uncovers a critical function of G[alpha]i/o signaling in accelerating breast cancer metastasis via the c-Src pathway. This work is clinically significant, as it can potentially pave the way to personalized therapies for patients who present with active G[alpha]i/o mutations or elevated Gαi/o signaling by targeting c-Src to inhibit breast cancer metastasis.

Targeting CD24 in Cancer Immunotherapy

“…Thus, further research and evidence are required to comprehend this topic fully [23]. Protein tyrosine kinase Src, particularly c-Src, is often overexpressed in a range of cancers and can be a significant factor in tumour progression [24,25]. The connection between CD24 and Src in relation to their location and function has been gradually recognised [26,27] (Figure 3).…”